CervoMed Inc. appointed Kelly Blackburn as Executive Vice President, Clinical Development with a salary of $448,360 effective April 16, 2025, and Mark De Rosch as Executive Vice President, Regulatory and Government Affairs with a salary of $465,000 effective May 1, 2025; Robert Cobuzzi will leave his role as COO on July 1, 2025, receiving a total of $479,723 plus bonuses and COBRA coverage.